journal article·2014-12-01Open access

Multirate delivery of multiple therapeutic agents from metal-organic frameworks

Alistair C. McKinlay, Phoebe K. Allan, Catherine L. Renouf, Morven J. Duncan, Paul S. Wheatley, Stewart J. Warrender, Daniel Dawson, Sharon E. Ashbrook, Barbara Gil, Bartosz Marszalek, Tina Düren, Jennifer J. Williams, Cedric Charrier, Derry K. Mercer, Simon J. Teat, Russell E. Morris

APL Materials· Volume 2· Issue 12

Abstract

The highly porous nature of metal-organic frameworks (MOFs) offers great potential for the delivery of therapeutic agents. Here, we show that highly porous metal-organic frameworks can be used to deliver multiple therapeutic agents—a biologically active gas, an antibiotic drug molecule, and an active metal ion—simultaneously but at different rates. The possibilities offered by delivery of multiple agents with different mechanisms of action and, in particular, variable timescales may allow new therapy approaches. Here, we show that the loaded MOFs are highly active against various strains of bacteria.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Metal-Organic Frameworks: Synthesis and Applications · Nanoplatforms for cancer theranostics · Covalent Organic Framework Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

University of St Andrews 1 EaStCHEM School of Chemistry, , St Andrews KY16 9ST, United Kingdom

Jagiellonian University 2 Faculty of Chemistry, , Ingardena 3, 30-060 Kraków, Poland

The University of Edinburgh 3 School of Engineering, Institute for Materials and Processes, , Edinburgh EH9 3JL, United Kingdom

NovaBiotics Ltd. 4 , Cruickshank Building, Craibstone, Aberdeen AB21 9TR, United Kingdom

5Advanced Light Source, Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Mail Stop 15-317, Berkeley, California 94720, USA

Funding

Engineering and Physical Sciences Research Council · British Heart Foundation

References (31)

Show source-provided references
1. Chem. Soc. Rev. · 2009 · 38 · 121310.1039/b903811f ↗
2. Science · 2003 · 300 · 112710.1126/science.1083440 ↗
3. Science · 2002 · 295 · 46910.1126/science.1067208 ↗
4. Nature · 2008 · 453 · 20710.1038/nature06900 ↗
5. Science · 2007 · 315 · 182810.1126/science.1137975 ↗
6. Nat. Chem. · 2009 · 1 · 28910.1038/nchem.254 ↗
7. Nat. Chem. · 2011 · 3 · 30410.1038/nchem.1003 ↗
8. Chem. Rev. · 2012 · 112 · 123210.1021/cr200256v ↗
9. Angew. Chem. · 2010 · 49 · 626010.1002/anie.201000048 ↗
10. Acc. Chem. Res. · 2011 · 44 · 95710.1021/ar200028a ↗
11. Nat. Mater. · 2010 · 9 · 17210.1038/nmat2608 ↗
12. J. Am. Chem. Soc. · 2008 · 130 · 1044010.1021/ja801997r ↗
13. CrystEngComm · 2013 · 15 · 936410.1039/c3ce41289j ↗
14. Nat. Rev. Drug Discovery · 2009 · 8 · 11110.1038/nrd2683 ↗
15. Angew. Chem. · 2005 · 44 · 635410.1002/anie.200501508 ↗
16. J. Am. Chem. Soc. · 2005 · 127 · 150410.1021/ja045123o ↗
17. Science · 1999 · 283 · 114810.1126/science.283.5405.1148 ↗
18. J. Am. Chem. Soc. · 2007 · 129 · 120310.1021/ja066098k ↗
19. Science · 2012 · 335 · 160610.1126/science.1217544 ↗
20. Proc. Natl. Acad. Sci. U. S. A. · 2009 · 106 · 2063710.1073/pnas.0909718106 ↗
21. J. Inorg. Biochem. · 2014 · 138 · 11410.1016/j.jinorgbio.2014.05.005 ↗
22. J. Am. Chem. Soc. · 2008 · 130 · 677410.1021/ja710973k ↗
23. Angew. Chem. · 2006 · 45 · 597410.1002/anie.200601878 ↗
24. Curr. Opin. Chem. Biol. · 2010 · 14 · 26210.1016/j.cbpa.2009.12.012 ↗
25. Microporous Mesoporous Mater. · 2010 · 129 · 33010.1016/j.micromeso.2009.04.031 ↗
26. Dalton Trans. · 2012 · 41 · 406010.1039/c2dt12069k ↗
27. Eur. J. Inorg. Chem. · 2008 · 23 · 362410.1002/ejic.200701284 ↗
28. See supplementary material at http://dx.doi.org/10.1063/1.4903290 for details of the synthesis, loading, and characterization of the materials.
29. Clin. Infect. Dis. · 2009 · 48 · 110.1086/595011 ↗
30. Clinical and Laboratory Standards Institute
31. J. Invest. Dermatol. · 2008 · 128 · 35210.1038/sj.jid.5701096 ↗